A Series C does not have to be enormous. Quadric's record — $90M raised across a ladder of rounds with a $46M Series C, backed by Pear VC, Uncork Capital, BEENEXT, Offline Ventures and the IFC — shows a deliberate pattern: raise what the next proof point costs, keep dilution compounding slowly, and let the stage label follow the business rather than lead it.
Key takeaways
- Round size should be set by the cost of the next proof point, not by the stage label.
- A Series C at roughly half of lifetime capital indicates a laddered cap table, not a step change.
- Cumulative dilution is the number to manage — three modest rounds can cost less ownership than one large one.
- Deep technical products often need staged capital because the risk retires in steps, not in one leap.
- A smaller late round keeps future options open; an oversized one sets a valuation bar you may not clear.
Most Series C coverage describes the extremes: nine-figure rounds, growth funds, secondary sales. That framing quietly tells founders their round is undersized. It usually is not.
Rather than describing a Series C in the abstract, this works through the sizing decision using a documented record: Daniel Firu, co-founder and Chief Product Officer at Quadric (Burlingame), which builds a programmable AI chip platform for running models on-device.
| | | |---|---| | Founder | Daniel Firu | | Company | Quadric (Burlingame, California) | | Category | AI semiconductors | | Total raised | $90M | | Latest round | Series C — $46M | | Round date | July 2026 | | Named backers on record | International Finance Corporation, Pear VC, Uncork Capital, BEENEXT, Offline Ventures |
The shape is the point. The Series C is roughly half of everything raised, which means the earlier rounds were meaningful, not token. This is a ladder, not a hockey stick of round sizes.
The useful question is never "what do companies raise at Series C." It is: what is the next thing that has to become true, and what does it cost?
For a hardware-adjacent company, those proof points are discrete — silicon that works, a reference design in a customer's product, a second design win that shows the first was not bespoke. Each one has a knowable cost and a knowable duration. Round size falls out of that arithmetic:
If the answer is $46M, raising $150M does not accelerate anything that money can accelerate. It buys a valuation you then have to grow into.
Three rounds of moderate size, spaced by proof, usually cost less ownership than one large round raised early, for a simple reason: each proven milestone raises the price of the next cheque. Dilution is not paid per round, it is paid per unit of uncertainty.
That is why the cumulative number is the one to track. Add your rounds together. Past roughly 40-50%, the question stops being valuation and starts being control — who decides when to sell, and at what price.
Concentration makes sense when the bottleneck is genuinely capital rather than learning: a fab commitment, a manufacturing line, entering three markets that each need local teams. The test is whether you can name what the extra $50M buys as an outcome, not as an activity. "Hire 40 people" is an activity. "Two design wins in automotive by Q4" is an outcome.
These figures come from structured funding records: total raised, round stage, round size, round date, and named participants. They do not include valuation, terms, board composition, or the reasoning behind the raise. Nothing here should be read as the founder's stated strategy — only as the shape the record supports.
Before your next round, write two numbers: the fully loaded cost of your next proof point, and your cumulative dilution to date. If the round you are planning is much larger than the first number, you are raising for optics. If the second number is already high, the size of the round matters less than who ends up holding the decision.
Frequently asked questions
- Is a $46M Series C too small?
- Size is only meaningful against the plan. In the record referenced here, $46M sat on top of a ladder totalling $90M — enough to fund a defined next milestone without resetting the valuation bar. A round is too small only if it cannot buy the next proof point.
- How do I decide how much to raise at Series C?
- Price the next proof point: the specific outcome that makes the following round obvious. Add the runway to reach it plus a buffer of two quarters, then check the dilution that implies against your cumulative total.
- Does a smaller round signal weakness to investors?
- Not inherently. Investors read round size relative to burn and milestone. A disciplined round with a clear use of funds reads better than an oversized one with a vague plan.
- What is a healthy cumulative dilution by Series C?
- There is no universal number, but founders past roughly 40-50% cumulative dilution should model who controls outcomes before adding another large round. Track the running total, not each round in isolation.
- Where do the figures in this article come from?
- From the structured founder funding records we maintain: total raised, round stage, round amount, round date, and named participants. They exclude valuation, deal terms and board composition.
